Rapid Growth of Radiopharmaceutical Therapy Highlights Need for Expertise

Nov. 11, 2025 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has released a position paper outlining the education, training and experience needed to ensure the safe and effective delivery of radiopharmaceutical therapy (RPT), a rapidly growing form of precision cancer treatment. Published in October in The Journal of Nuclear Medicine, the paper underscores SNMMI’s leadership in setting standards and guiding the global expansion of this transformative field.